Internal Medicine, Gastroenterology · Evanston, IL
NPI
1154526770
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
800 Austin St Ste 403
Evanston, IL, 60202
Phone (847) 491-9020
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
1,349 services
Medicare patients, 2024
354
Average age 72
Drug cost, 2024
$928K
1,062 prescriptions
Company payments, 2025
$200K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daksesh B Patel was code 99214 (office e&m - established), 161 times for 109 patients. In total Daksesh B Patel billed 1,349 services in 45 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 161 | 109 | $92.71 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 98 | 62 | $61.14 | $5,992 |
| 45385 Colonoscopy - Lesion Removal | Facility | 80 | 75 | $213.41 | $17K |
| 43239 Upper GI Endoscopy | Facility | 71 | 70 | $61.21 | $4,346 |
| 99204 Office E&M - New | Office | 64 | 64 | $130.52 | $8,354 |
| 45380 Lower GI Endoscopy - Other | Facility | 45 | 43 | $81.37 | $3,662 |
| 99222 Hospital E&M - Initial | Facility | 34 | 34 | $105.18 | $3,576 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 22 | 22 | $165.58 | $3,643 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 21 | 20 | $170.38 | $3,578 |
| 45381 Lower GI Endoscopy - Other | Facility | 20 | 18 | $12.57 | $251 |
| 99213 Office E&M - Established | Office | 16 | 16 | $68.00 | $1,088 |
| 99443 Telephone Services | Office | 12 | 12 | $96.82 | $1,162 |
By year: 2022 $86K for 815 services; 2023 $70K for 650 services; 2024 $93K for 1,349 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daksesh B Patel prescribed most often to Medicare patients was Omeprazole, with 237 prescriptions and refills. In total Daksesh B Patel wrote 1,062 Medicare prescriptions that cost $928K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 237 | 490 | 97 | $2,640 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 188 | 188 | 184 | $2,854 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 56 | 56 | 52 | $881 |
| Dicyclomine Hcl Generic | 53 | 62 | 20 | $774 |
| Pantoprazole Sodium Generic | 48 | 131 | 21 | $631 |
| Sucraid Sacrosidase | 44 | 44 | 12 | $616K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 39 | 39 | 37 | $677 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 37 | 37 | 35 | $2,577 |
| Amitriptyline Hcl Generic | 25 | 39 | 11 | $209 |
| Linzess Linaclotide | 24 | 54 | Under 11 | $29K |
| Famotidine Generic | 20 | 40 | Under 11 | $235 |
| Cholestyramine Light Cholestyramine | 19 | 23 | Under 11 | $1,421 |
| Voquezna Vonoprazan Fumarate | 19 | 25 | Under 11 | $16K |
| Xifaxan Rifaximin | 17 | 17 | 11 | $35K |
| Motegrity Prucalopride Succinate | 17 | 35 | Under 11 | $19K |
Brand drugs: 286 claims; generic drugs: 776 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daksesh B Patel $200K ($200K in general payments such as food, travel and fees) from 24 companies. The largest payer was QOL Medical, LLC with $131K.
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 234 | $131K |
| Phathom Pharmaceuticals, Inc. PHAT | 75 | $54K |
| Evoke Pharma, Inc. EVOK | 15 | $11K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 40 | $860 |
| Abbvie Inc. ABBV | 22 | $413 |
| Genzyme Corporation SNY | 11 | $374 |
| Janssen Biotech, Inc. JNJ | 13 | $320 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 15 | $272 |
| Ardelyx, Inc. ARDX | 12 | $254 |
| Pfizer Inc. PFE | 9 | $185 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.